Biogen (BIIB) Q4 2024 Earnings Call Transcript todayheadline
BIIB earnings call for the period ending December 31, 2024. Image source: The Motley Fool. Biogen (BIIB -5.90%)Q4 2024 Earnings ...
Read moreDetailsTag: Biogen
US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug
(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's Alzheimer's ...
Read moreDetailsBiogen CEO sees no burning need for more acquisitions
By Deena Beasley SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches to exceed its current sales by 2028 ...
Read moreDetailsBiogen proposes to buy remaining stake in Sage in $442 million deal
(Reuters) - Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 ...
Read moreDetails
